Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Managed care aspects of managing multiple sclerosis.
Our products
Behavioral Neurology of Multiple Sclerosis and Autoimmune Encephalopathies.
Psychometric Properties of the Arab Heritage Activity Card Sort.
Microstructural magnetic resonance imaging of cortical lesions in multiple sclerosis.
Determinants of central nervous system adult neurogenesis are sex, hormones, mouse strain, age, and brain region.
Smoking and inflammation: evidence for a synergistic role in chronic disease.
Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells.
Excitotoxicity: Bridge to various triggers in neurodegenerative disorders.
Cholesterol Modification of p40-Specific Small Interfering RNA Enables Therapeutic Targeting of Dendritic Cells.
Statistical estimation of T1 relaxation times using conventional magnetic resonance imaging.
Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis.
PERK Dependent Activation of JAK1 and STAT3 Contributes to ER Stress Induced Inflammation.
Plasma biomarkers discriminate clinical forms of multiple sclerosis.
Type I interferons as ambiguous modulators of chronic inflammation in the central nervous system.
Could behavioral therapies target specific deficits in multiple sclerosis patients?
[Pharmacological treatment of spasticity in multiple sclerosis].
Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis.
Diffusion tensor imaging based network analysis detects alterations of neuroconnectivity in patients with clinically early relapsing-remitting multiple sclerosis.
Hematopoietic Stem Cell Therapy for Multiple Sclerosis: Top 10 Lessons Learned.
High rates of physician services utilization at least five years before multiple sclerosis diagnosis.
Improved determination of the myelin water fraction in human brain using magnetic resonance imaging through Bayesian analysis of mcDESPOT.
Fingolimod after natalizumab and the risk of short-term relapse.
'Green Mice' display limitations in enhanced green fluorescent protein expression in retina and optic nerve cells.
OPtimizing CNS drug development using molecular imaging.
Pages
« first
‹ previous
…
280
281
282
283
284
285
286
287
288
…
next ›
last »